However, there are concerns regarding the use of IL-2 to enhance immune responses, including its activity on lung endothelial cells and CD4+CD25+ regulatory T (Treg) cells through binding to CD25, leading to vascular leak syndrome including pulmonary oedema and to preferential expansion of Treg cells, respectively. Here, IL2RA is linked to pulmonary edema.